Form D — BTB Therapeutics, Inc.
0002055053-25-000001 · filed Feb 5, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $3,333,415
- Reported amount sold
- $3,333,333
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BTB Therapeutics, Inc.
- CIK
- 2055053
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 26281 WYNDEMERE COURT
ESCONDIDO, CA 92026 - Phone
- (858) 945-3733
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Takashi Kiyoizumi · Executive OfficerEscondido, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗